{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:14:52Z","timestamp":1789636492452,"version":"4.0.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.urolonc.2020.08.033","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T21:44:56Z","timestamp":1601588696000},"page":"194.e17-194.e24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Trends in management of ureteral urothelial carcinoma and effects on survival: a hospital-based registry study"],"prefix":"10.1016","volume":"39","author":[{"given":"Patrick M.","family":"Lec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Venkataramana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Lenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Fero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishnukamal","family":"Golla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Gollapudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Blumberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Chamie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2020.08.033_bib0001","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00345-016-1928-x","article-title":"Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)","volume":"35","author":"Soria","year":"2017","journal-title":"World J. Urol."},{"key":"10.1016\/j.urolonc.2020.08.033_bib0002","first-page":"43","article-title":"Cancer Statistics, 2019","volume":"57","author":"Jemal","year":"2019","journal-title":"CA. Cancer J. Clin"},{"key":"10.1016\/j.urolonc.2020.08.033_bib0003","first-page":"1","article-title":"EAU Guidelines on Upper Urinary Tract Urothelial Carcinoma 2019","author":"Roupr\u00eat","year":"2019","journal-title":"Eur. Assoc. Urol. Guid. 2019 Ed."},{"key":"10.1016\/j.urolonc.2020.08.033_bib0004","unstructured":"Flaig TW, Spiess PE, \u03a0 M, et al. National Comprehensive Cancer Network. Bladder Cancer (Version 1.2020). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/bladder.pdf. Accessed March 22, 2020."},{"key":"10.1016\/j.urolonc.2020.08.033_bib0005","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1002\/cncr.25043","article-title":"Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy","volume":"116","author":"Lane","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2020.08.033_bib0006","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1001\/jamaoncol.2016.6905","article-title":"Using the national cancer database for outcomes research a review","volume":"3","author":"Boffa","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.urolonc.2020.08.033_bib0007","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1442-2042.2006.01664.x","article-title":"Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer","volume":"14","author":"Secin","year":"2007","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.urolonc.2020.08.033_bib0008","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1442-2042.2012.03009.x","article-title":"Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract","volume":"19","author":"Kondo","year":"2012","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.urolonc.2020.08.033_bib0009","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.juro.2007.05.158","article-title":"Impact of the Extent of Regional Lymphadenectomy on the Survival of Patients With Urothelial Carcinoma of the Upper Urinary Tract","volume":"178","author":"Kondo","year":"2007","journal-title":"J. Urol."},{"key":"10.1016\/j.urolonc.2020.08.033_bib0010","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.eururo.2007.04.070","article-title":"Retroperitoneal Lymph Node Dissection (RPLD) in Conjunction with Nephroureterectomy in the Treatment of Infiltrative Transitional Cell Carcinoma (TCC) of the Upper Urinary Tract: Impact on Survival{A figure is presented}","volume":"52","author":"Brausi","year":"2007","journal-title":"Eur. Urol."},{"key":"10.1016\/j.urolonc.2020.08.033_bib0011","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1186\/s12885-019-6364-z","article-title":"Effect of lymph node dissection on stage-specific survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy","volume":"19","author":"Zhai","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urolonc.2020.08.033_bib0012","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.urology.2006.10.014","article-title":"Primary Site and Incidence of Lymph Node Metastases in Urothelial Carcinoma of Upper Urinary Tract","volume":"69","author":"Kondo","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2020.08.033_bib0013","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5306\/wjco.v6.i6.237","article-title":"Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract","volume":"6","author":"Kondo","year":"2015","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.urolonc.2020.08.033_bib0014","first-page":"1","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","volume":"6736","author":"Birtle","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2020.08.033_bib0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2014.03.003","article-title":"A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma","volume":"66","author":"Leow","year":"2014","journal-title":"Eur. Urol."},{"key":"10.1016\/j.urolonc.2020.08.033_bib0016","doi-asserted-by":"crossref","DOI":"10.1007\/s10147-020-01650-9","article-title":"Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis","author":"Quhal","year":"2020","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.urolonc.2020.08.033_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-10873-y","article-title":"Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling","volume":"10","author":"Robinson","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.urolonc.2020.08.033_bib0018","series-title":"Molecular Analysis of Upper Tract and Bladder Urothelial Carcinoma: Results from a Microarray Comparison","author":"Sanford","year":"2015"},{"key":"10.1016\/j.urolonc.2020.08.033_bib0019","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.eururo.2010.06.029","article-title":"Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy","volume":"58","author":"Kaag","year":"2010","journal-title":"Eur. Urol."},{"key":"10.1016\/j.urolonc.2020.08.033_bib0020","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/j.clgc.2019.10.015","article-title":"Segmental ureterectomy for upper tract urothelial carcinoma: a systematic review and meta-analysis of comparative studies","volume":"18","author":"Veccia","year":"2019","journal-title":"Clin. Genitourin. Cancer"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920304026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920304026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:19:42Z","timestamp":1761041982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143920304026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1078143920304026"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.08.033","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in management of ureteral urothelial carcinoma and effects on survival: a hospital-based registry study","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.08.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}